RETA

Reata Pharmaceuticals, Inc. Class A Common Stock

Delisted

RETA was delisted on the 25th of September, 2023.

181 hedge funds and large institutions have $2.69B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 71 increasing their positions, 55 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
181
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$39.3M
Puts
$94.7M
Net Calls
Net Calls Change

Top Buyers

1 +$63.3M
2 +$22.1M
3 +$11.6M
4
Morgan Stanley
Morgan Stanley
New York
+$9.65M
5
SI
Sofinnova Investments
California
+$7.84M

Top Sellers

1 -$42.5M
2 -$36.6M
3 -$11.1M
4
Ameriprise
Ameriprise
Minnesota
-$10.1M
5
CA
Corriente Advisors
Texas
-$10.1M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$1.76M
77
$1.71M
78
$1.71M
79
$1.57M
80
$1.53M
81
$1.51M
82
$1.51M
83
$1.43M
84
$1.36M
85
$1.36M
86
$1.27M
87
$1.25M
88
$1.17M
89
$1.14M
90
$1.11M
91
$1.07M
92
$1.03M
93
$1.02M
94
$1.01M
95
$990K
96
$930K
97
$885K
98
$832K
99
$758K
100
$746K